Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Cisplatin and Radiation in Cervical Cancer
NCT00510250Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in Cervical Cancer (CC), sponsored by University Health Network. Started Jun 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00510250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510250.